BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17304461)

  • 41. Gastrointestinal infections after transplantation.
    Danziger-Isakov L
    Curr Opin Gastroenterol; 2014 Jan; 30(1):40-6. PubMed ID: 24257036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bacterial and mycobacterial pneumonia in transplant recipients.
    Gasink LB; Blumberg EA
    Clin Chest Med; 2005 Dec; 26(4):647-59, vii. PubMed ID: 16263403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients.
    Lang P; Mueller I; Greil J; Bader P; Schumm M; Pfeiffer M; Hoelle W; Klingebiel T; Heinzelmann F; Belka C; Schlegel PG; Kremens B; Woessmann W; Handgretinger R
    Blood Cells Mol Dis; 2008; 40(1):33-9. PubMed ID: 17884640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hematopoietic stem cell transplantation in patients with active fungal infection: not a contraindication for transplantation.
    Aki ZS; Sucak GT; Yeğin ZA; Güzel O; Erbaş G; Senol E
    Transplant Proc; 2008 Jun; 40(5):1579-85. PubMed ID: 18589155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
    Ward HJ
    J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy.
    Marty FM; Rubin RH
    Transpl Int; 2006 Jan; 19(1):2-11. PubMed ID: 16359371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
    Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
    Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relevance of minor histocompatibility antigens in solid organ transplantation.
    Dierselhuis M; Goulmy E
    Curr Opin Organ Transplant; 2009 Aug; 14(4):419-25. PubMed ID: 19444105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Has stem cell transplantation come of age in the treatment of sickle cell disease?
    Shenoy S
    Bone Marrow Transplant; 2007 Nov; 40(9):813-21. PubMed ID: 17704797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pulmonary complications of solid organ and hematopoietic stem cell transplantation.
    Kotloff RM; Ahya VN; Crawford SW
    Am J Respir Crit Care Med; 2004 Jul; 170(1):22-48. PubMed ID: 15070821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Infections transmitted by transplantation.
    Morris MI; Fischer SA; Ison MG
    Infect Dis Clin North Am; 2010 Jun; 24(2):497-514. PubMed ID: 20466280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infectious complications following unrelated cord blood transplantation.
    van Burik JA; Brunstein CG
    Vox Sang; 2007 May; 92(4):289-96. PubMed ID: 17456152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel antibodies to the donor stem cell population CD34+/VEGFR-2+ are associated with rejection after hematopoietic stem cell transplantation.
    Nordlander A; Mattsson J; Sundberg B; Sumitran-Holgersson S
    Transplantation; 2008 Sep; 86(5):686-96. PubMed ID: 18791450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
    Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The most common infections in the transplanted patient].
    Yuste JR; del Pozo JL; Quetglás EG; Azanza JR
    An Sist Sanit Navar; 2006; 29 Suppl 2():175-205. PubMed ID: 16998526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT.
    Ljungman P; Engelhard D; de la Cámara R; Einsele H; Locasciulli A; Martino R; Ribaud P; Ward K; Cordonnier C;
    Bone Marrow Transplant; 2005 Apr; 35(8):737-46. PubMed ID: 15750612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation.
    Ciuffreda D; Pantaleo G; Pascual M
    Transpl Int; 2007 Aug; 20(8):649-58. PubMed ID: 17425723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solid organ transplant donors with central nervous system infection.
    Kaul DR; Covington S; Taranto S; Green M; Lyon GM; Kusne S; Miller RA; Blumberg EA
    Transplantation; 2014 Sep; 98(6):666-70. PubMed ID: 24914569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.